Cost-effectiveness of tirofiban for acute ischemic stroke without large or medium-sized vessel occlusion: A Markov modelling analysis from the Chinese and United States perspectives.
Saved in:
| Title: | Cost-effectiveness of tirofiban for acute ischemic stroke without large or medium-sized vessel occlusion: A Markov modelling analysis from the Chinese and United States perspectives. |
|---|---|
| Authors: | Wang, Li1 (AUTHOR), Zeng, Yuhong2,3 (AUTHOR), Zhou, Limei1 (AUTHOR), Xu, Ping1 (AUTHOR), Guo, Xianbin1 (AUTHOR), Xie, Yu1 (AUTHOR), Cai, Junxiu1 (AUTHOR), Pan, Min1 (AUTHOR), Tang, Jie1 (AUTHOR), Gong, Qingtao1 (AUTHOR), Su, Rong1 (AUTHOR), Liu, Yan1 (AUTHOR), Lou, Yake4 (AUTHOR) yk_lou@stu.cqmu.edu.cn |
| Source: | PLoS ONE. 2/16/2024, Vol. 19 Issue 3, p1-15. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19326203 |
|---|---|
| DOI: | 10.1371/journal.pone.0297939 |
